FDA authorizes marketing of first diagnostic test for detecting Zika virus antibodies

Previously, tests for detecting Zika virus IgM antibodies had been authorized only for emergency use under the FDA’s Emergency Use Authorization (EUA) authority.

Source link

Related posts

MESEMS: No Reduction in MS Lesions With Stem Cell Therapy


The association between socioeconomic status and depression among older adults in Finland, Poland and Spain: A comparative cross-sectional study of distinct measures and pathways.


Modifiable CV Risk Factors Within Healthy Range Indicative of CV Morphology, White Matter Lesions


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy